Works matching IS 03331024 AND DT 2021 AND VI 41 AND IP 13


Results: 16
    1

    Call for papers.

    Published in:
    Cephalalgia, 2021, v. 41, n. 13, p. 1283, doi. 10.1177/03331024211050406
    Publication type:
    Article
    2
    3
    4
    5
    6
    7

    Randomised, controlled trial of erenumab for the prevention of episodic migraine in patients from Asia, the Middle East, and Latin America: The EMPOwER study.

    Published in:
    Cephalalgia, 2021, v. 41, n. 13, p. 1285, doi. 10.1177/03331024211024160
    By:
    • Wang, Shuu-Jiun;
    • Roxas Jr, Artemio A;
    • Saravia, Bibiana;
    • Kim, Byung-Kun;
    • Chowdhury, Debashish;
    • Riachi, Naji;
    • Tai, Mei-Ling Sharon;
    • Tanprawate, Surat;
    • Ngoc, Tai Tran;
    • Zhao, Yi Jing;
    • Mikol, Daniel D;
    • Pandhi, Shaloo;
    • Wen, Shihua;
    • Mondal, Subhayan;
    • Tenenbaum, Nadia;
    • Hours-Zesiger, Peggy
    Publication type:
    Article
    8
    9
    10
    11

    Assessing migraine therapeutics.

    Published in:
    Cephalalgia, 2021, v. 41, n. 13, p. 1402, doi. 10.1177/03331024211021569
    By:
    • Xu, Cen;
    • Bussiere, Jeanine
    Publication type:
    Article
    12
    13
    14
    15
    16